Literature DB >> 31085105

Genetic Variants Associated with Cancer Pain and Response to Opioid Analgesics: Implications for Precision Pain Management.

Gee Su Yang1, Natalie M Barnes2, Debra E Lyon2, Susan G Dorsey3.   

Abstract

OBJECTIVE: To review the current knowledge on the association of genetic variants with cancer pain. DATA SOURCES: Data-based publications and review articles retrieved from PubMed, CINAHL, and Web of Science, as well as an additional search in Google Scholar.
CONCLUSION: Genetic variability can influence differential pain perception and response to opioids in cancer patients, which will have implications in the optimal personalized treatment of cancer pain. More studies are warranted to replicate findings. IMPLICATIONS FOR NURSING PRACTICE: Nurses are poised to educate patients on biomarker testing and interpretation and to use precision pain management strategies based on this information.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; Cancer; Genetic polymorphism; Genetic variant; Pain; Precision medicine

Mesh:

Substances:

Year:  2019        PMID: 31085105      PMCID: PMC6688486          DOI: 10.1016/j.soncn.2019.04.011

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  72 in total

1.  Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer.

Authors:  Didier Bouhassira; Elisabeth Luporsi; Ivan Krakowski
Journal:  Pain       Date:  2017-06       Impact factor: 6.961

Review 2.  Update and review on the basics of pain management.

Authors:  Ahmed A Al-Sayed; Abdulaziz M Al-Numay
Journal:  Neurosciences (Riyadh)       Date:  2011-07       Impact factor: 0.906

3.  Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery.

Authors:  Kimberly Stephens; Bruce A Cooper; Claudia West; Steven M Paul; Christina R Baggott; John D Merriman; Anand Dhruva; Kord M Kober; Dale J Langford; Heather Leutwyler; Judith A Luce; Brian L Schmidt; Gary M Abrams; Charles Elboim; Deborah Hamolsky; Jon D Levine; Christine Miaskowski; Bradley E Aouizerat
Journal:  J Pain       Date:  2013-10-12       Impact factor: 5.820

4.  The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.

Authors:  P Klepstad; T T Rakvåg; S Kaasa; M Holthe; O Dale; P C Borchgrevink; C Baar; T Vikan; H E Krokan; F Skorpen
Journal:  Acta Anaesthesiol Scand       Date:  2004-11       Impact factor: 2.105

5.  Online discussion of drug side effects and discontinuation among breast cancer survivors.

Authors:  Jun J Mao; Annie Chung; Adrian Benton; Shawndra Hill; Lyle Ungar; Charles E Leonard; Sean Hennessy; John H Holmes
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-01-16       Impact factor: 2.890

6.  Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study.

Authors:  Francoise Laroche; Joël Coste; Terkia Medkour; Paul Henri Cottu; Jean-Yves Pierga; Jean-Pierre Lotz; Karine Beerblock; Christophe Tournigand; Xavier Declèves; Patricia de Cremoux; Didier Bouhassira; Serge Perrot
Journal:  J Pain       Date:  2013-12-21       Impact factor: 5.820

Review 7.  Genetic predictors of human chronic pain conditions.

Authors:  Katerina Zorina-Lichtenwalter; C B Meloto; S Khoury; L Diatchenko
Journal:  Neuroscience       Date:  2016-04-30       Impact factor: 3.590

Review 8.  Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis.

Authors:  Marieke H J van den Beuken-van Everdingen; Laura M J Hochstenbach; Elbert A J Joosten; Vivianne C G Tjan-Heijnen; Daisy J A Janssen
Journal:  J Pain Symptom Manage       Date:  2016-04-23       Impact factor: 3.612

9.  Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A.

Authors:  Cielito C Reyes-Gibby; Margaret Spitz; Xifeng Wu; Kelly Merriman; Carol Etzel; Eduardo Bruera; Razelle Kurzrock; Sanjay Shete
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

Review 10.  Pharmacogenetics of chronic pain and its treatment.

Authors:  Svatopluk Světlík; Karolína Hronová; Hana Bakhouche; Olga Matoušková; Ondřej Slanař
Journal:  Mediators Inflamm       Date:  2013-05-20       Impact factor: 4.711

View more
  3 in total

1.  Approaches to opioid prescribing in cancer survivors: Lessons learned from the general literature.

Authors:  Katie Fitzgerald Jones; Jessica S Merlin
Journal:  Cancer       Date:  2021-10-11       Impact factor: 6.860

Review 2.  Association of genetic polymorphisms with psychological symptoms in cancer: A systematic review.

Authors:  Sek Ying Chair; Bernard M H Law; Judy Y W Chan; Winnie K W So; Mary M Y Waye
Journal:  Asia Pac J Oncol Nurs       Date:  2021-12-25

3.  Genome-Wide Association Study Identifies Candidate Loci Associated with Opioid Analgesic Requirements in the Treatment of Cancer Pain.

Authors:  Daisuke Nishizawa; Takeshi Terui; Kunihiko Ishitani; Shinya Kasai; Junko Hasegawa; Kyoko Nakayama; Yuko Ebata; Kazutaka Ikeda
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.